STRAIN FOR THE TREATMENT AND/OR PREVENTION OF CHRONIC INFLAMMATORY DISEASES
Idioma
en
Brevet
Este ítem está publicado en
2016
Resumen en inglés
The present invention concerns the probiotic strain Bacillus subtilis CU1 filed with the French Collection Nationale de Culture des Microorganismes (National Collection of Microorganism Cultures) under number I-2745, cells ...Leer más >
The present invention concerns the probiotic strain Bacillus subtilis CU1 filed with the French Collection Nationale de Culture des Microorganismes (National Collection of Microorganism Cultures) under number I-2745, cells obtained by culturing said strain and a composition comprising cells obtained by culturing said strain, for the use thereof in the treatment and/or prevention of chronic inflammatory diseases, and in particular chronic inflammatory rheumatism.< Leer menos
N° de patente
US20160136209Centros de investigación